IDH2 and central nervous system cancer: Another consequence of deregulated IDH metabolism in IDH-mutated glioma cells is the downregulation of leukocyte chemotaxis, leading to a significant reduction of most immune cells (macrophages, microglia, CD8+ CD4+, B cells, and dendritic cells).